Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80352
New York State Approval Status

Approved

Turnaround Time

7 days

Test Includes
1 ADMB-FUBINACA ADB-FUBINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1.0 Synthetic Cannabinoid
2 5-fluoro-PICA 3,3-dimethylbutanoic acid 5-fluoro MDMB-PICA metabolite 7 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
3 5-fluoro-PINACA 3-methylbutanoic acid 5-fluoro AMB metabolite 7 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
4 4-fluoro-BINACA 3,3-dimethylbutanoic acid 4-fluoro MDMB BINACA butanoic acid metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
5 FUBINACA 3-methylbutanoic acid FUB-AMB 3-methyl-butanoic acid; MMB-FUBINACA metabolite 1 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
6 5-fluoro-PINACA 3,3-dimethylbutanoic acid 5-fluoro-ADB metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
7 FUBINACA 3,3-dimethylbutanoic acid MDMB-FUBINACA metabolite 1 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
8 APP-BINACA APP-BUTINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
9 5-fluoro-MDMB-PICA / 5-fluoro-EMB-PICA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
10 MMB-FUBINACA AMB-FUBINACA, FUB-AMB High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
11 5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA 5-fluoro-ADB/5-fluoro-AEB High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.2 Synthetic Cannabinoid
12 MDMB-4en-PINACA MDMB-PENINACA; MDMB-PINACA N1-pentyl-4-en isomer High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
13 ADMB-CHMINACA ADB-CHMINACA; MAB-CHMINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
14 4-fluoro-MDMB-BINACA 4-fluoro-MDMB-BUTINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid

Test Also Known As
K2; Spice; Synthetic Cannabinoid
Compliance Statement
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.
Sample Type
Serum or Plasma
Requested Volume
2 mL
Minimum Volume
0.7 mL
Special Handling
Serum: Collect sample in Red top tube
Plasma: Collect sample in Lavender top tube (EDTA) or Pink top tube.
Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines.
Sample Container
Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
Polymer gel separation tube (SST or PST).

Rejection criteria pertain to clinical sample submissions only.

Stability
Room Temperature: 30 day(s)
Refrigerated: 30 day(s)
Frozen (-20 °C): 30 day(s)
1 ADMB-FUBINACA ADB-FUBINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1.0 Synthetic Cannabinoid
2 5-fluoro-PICA 3,3-dimethylbutanoic acid 5-fluoro MDMB-PICA metabolite 7 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
3 5-fluoro-PINACA 3-methylbutanoic acid 5-fluoro AMB metabolite 7 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
4 4-fluoro-BINACA 3,3-dimethylbutanoic acid 4-fluoro MDMB BINACA butanoic acid metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
5 FUBINACA 3-methylbutanoic acid FUB-AMB 3-methyl-butanoic acid; MMB-FUBINACA metabolite 1 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
6 5-fluoro-PINACA 3,3-dimethylbutanoic acid 5-fluoro-ADB metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
7 FUBINACA 3,3-dimethylbutanoic acid MDMB-FUBINACA metabolite 1 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
8 APP-BINACA APP-BUTINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
9 5-fluoro-MDMB-PICA / 5-fluoro-EMB-PICA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
10 MMB-FUBINACA AMB-FUBINACA, FUB-AMB High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
11 5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA 5-fluoro-ADB/5-fluoro-AEB High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.2 Synthetic Cannabinoid
12 MDMB-4en-PINACA MDMB-PENINACA; MDMB-PINACA N1-pentyl-4-en isomer High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
13 ADMB-CHMINACA ADB-CHMINACA; MAB-CHMINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
14 4-fluoro-MDMB-BINACA 4-fluoro-MDMB-BUTINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid

Interface Map

LOINC® Information

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.